Showing 121-130 of 447 results for "".
Treating Severe Acne in Transgender Patients: An Update
https://practicaldermatology.com/columns/clinical-focus-1/treating-severe-acne-in-transgender-patients-an-update/23472/Understanding the implications of isotretinoin use in FTM acne patients.Niacinamide: A Multi-functional Cosmeceutical Ingredient
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/niacinamide-a-multi-functional-cosmeceutical-ingredient/23720/This non-irritating, water-soluble essential vitamin may benefit a variety of skin conditions.New Products
https://practicaldermatology.com/topics/practice-management/new-products/21198/Thick Melanomas: Assessing Prognosis
https://practicaldermatology.com/topics/skin-cancer-photoprotection/thick-melanomas-assessing-prognosis/23685/New data identifies stratified risk based on the thickness of melanomas thicker than 4mm.Can AI and Digital Innovation Improve the Patient Experience?
https://practicaldermatology.com/topics/practice-management/can-ai-and-digital-innovation-improve-the-patient-experience/23964/Embrace AI and how it can help improve points of contact with your patients.Miliary Osteoma Cutis: An Unusual, Sudden-Onset Presentation of a Rare Eruption; Call for Cases
https://practicaldermatology.com/youngmd-connect/resident-resource-center/miliary-osteoma-cutis-an-unusual-sudden-onset-presentationof-a-rare-eruption-call-for-cases/23067/A Guide to Building Lifelong Patient Loyalty
https://practicaldermatology.com/issues/october-2025/a-guide-to-building-lifelong-patient-loyalty/39758/Interest in medical aesthetic treatments continues to grow and signs indicate that demand will remain strong. Today’s patients are more informed and educated than ever and are seeking personalized, high-quality experiences.Who's Afraid of the Big Black Box?
https://practicaldermatology.com/topics/psoriasis/whos-afraid-of-the-big-black-box/20286/Weighing the Prospects of Biosimilars
https://practicaldermatology.com/columns/clinical-focus-1/weighing-the-prospects-of-biosimilars/21477/If they are found to be comparable to the “originators,” biosimilar agents may offer patients significant therapeutic benefits as well as cost efficiency.New products and pharmacologic developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacologic-developments/21688/